N/A
Completed N=776
PROmotion of FLU Vaccine Uptake in the Emergency Department - PROFLUVAXED
Influenza Vaccination
Source: ClinicalTrials.gov NCT05836818 ↗
Enrolled (actual)
776
Serious AEs
0.0%
Results posted
May 2024
Primary outcomePrimary: Influenza Vaccine Uptake at 30 Days Comparing Intervention M and Non Intervention — 86; 47 Participants — p=<0.0001
Summary
The goal of this research is to increase influenza vaccine acceptance and uptake in vulnerable populations whose primary (and often only) health care access occurs in emergency departments (ED Usual Source of Care Patients). Toward this goal, the investigators will conduct one on one interviews and focus groups with ED Usual Source of Care Patients and community partners and produce trusted messaging informational platforms (PROmotion of FLU VA(X)ccination in the Emergency Department - PROFLUVAXED) that will address barriers to flu vaccination, especially vaccine hesitancy. The investigators will then conduct a cluster-randomized, controlled trial of PROFLUVAXED platforms in six EDs to determine whether their implementation is associated with greater flu vaccine acceptance and uptake in ED Usual Source of Care Patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Influenza Vaccine Uptake at 30 Days Comparing Intervention M and Non Intervention |
86; 47 | <0.0001 sig |
| SECONDARY Vaccine Acceptance |
103; 110 | — |
| SECONDARY Influenza Vaccine Uptake at 30 Days Comparing Intervention Q and Non-Intervention Group |
78; 47 | — |
Eligibility Criteria
Inclusion Criteria
- Adults
- Presenting to ED
- Not already vaccinated for influenza in the current year
- Able to provide informed consent
- Fluent in English or Spanish
- Anticipated ability to complete study intervention in ED i.e., able to watch a 3-minute videoclip
Exclusion Criteria
- Age < 18 years
- Major trauma such that it will preclude survey
- Inability to participate in a survey because of intoxication, altered mental status, or critical illness
- Incarceration
- Psychiatric hold
- We will also exclude patients who state that they have already received an influenza vaccine and patients who are in the ED for suspected acute Covid or influenza illness.
Data sourced from ClinicalTrials.gov (NCT05836818). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.